drugset / Trial / NCT00808964

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery

NCT00808964 ↗

Phase 2 Unknown 30 enrolled ARCA Biopharma, Inc.
Non-randomizedSingle-groupOpen-label

Summary

This is a Phase 2, multicenter, open-label, single-arm, sequential cohort study to be conducted in up to 30 subjects. The study will evaluate subjects undergoing primary, elective, off-pump CABG surgery with median sternotomy.

Timeline

Start
2013-01
Primary completion
2013-06
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject NU172 Unknown — Intravenous

Indications